In this contribution, a novel cellulose acetate modified with dopamine (CA-DA) membrane material was designed and prepared by a two-step route consist of chlorination and further substitution reactions. The chemical structure of the prepared CA-DA material was determined by FTIR and H NMR, respectively. The CA-DA ultrafiltration membrane was subsequently fabricated by the scalable phase inversion process. Compared with cellulose acetate membrane as the control sample, the introduction of dopamine improved the porosity, pore size and hydrophilicity of the CA-DA membrane, which was helpful to the water permeability (181.2 L/mh) without obviously affecting the protein rejection (93.5%). According to the static protein adsorption and dynamic cycle ultrafiltration experiments, the CA-DA membrane displayed persistent antifouling performance, which was verified by flux recovery ratio, flux decline ratio and filtration resistance. Moreover, the water flux recovery ratio of the CA-DA membrane was retained at 97.3% after three-cycles of BSA solution filtration, which was much higher than that of the reference CA membrane. This new approach provided a long life and excellent ultrafiltration performance for polymer-based membranes, which has potential application prospects in the field of separation process.
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1016/j.ijbiomac.2020.05.223 | DOI Listing |
Photodynamic therapy (PDT) has emerged as a highly efficacious therapeutic modality for malignant tumors owing to its non-invasive property and minimal adverse effects. However, the pervasive hypoxic microenvironment within tumors significantly compromises the efficacy of oxygen-dependent PDT, posing a formidable challenge to the advancement of high-efficiency PDT. Here, we developed a nanostructured photosensitizer (PS) assembled by cationic and anionic zinc phthalocyanines to load oxygen-throttling drug atovaquone (ATO), which was subsequently coated with polydopamine to obtain the final product ATO/ZnPc-CA@DA.
View Article and Find Full Text PDFInt J Biol Macromol
October 2020
College of Material Science and Engineering, Northeast Forestry University, Harbin 150040, PR China; Key Laboratory of Bio-based Materials Science & Technology, Ministry of Education, Northeast Forestry University, Harbin 150040, PR China. Electronic address:
In this contribution, a novel cellulose acetate modified with dopamine (CA-DA) membrane material was designed and prepared by a two-step route consist of chlorination and further substitution reactions. The chemical structure of the prepared CA-DA material was determined by FTIR and H NMR, respectively. The CA-DA ultrafiltration membrane was subsequently fabricated by the scalable phase inversion process.
View Article and Find Full Text PDFAm J Psychiatry
July 2004
Department of Psychiatry, Abramson Cancer Center, University of Pennsylvania, Suite 4100, 3535 Market Street, Philadelphia, PA 19104, USA.
Objective: The goal of the present study was to identify specific genetic associations with smoking progression in adolescents and to determine whether these genetic effects on smoking practices are potentiated by depression symptoms.
Method: Effects of dopamine transporter (SLC6A3) and dopamine receptor (DRD2) genetic variants on smoking progression were evaluated in a cohort of 615 adolescents, including those who had never smoked, and in a subgroup including only adolescents who had been exposed to nicotine (i.e.
Am J Clin Nutr
July 2004
Departments of Pediatrics, School of Medicine and Biomedical Sciences, State University of New York at Buffalo, 14214-3000, USA.
Background: Food reinforcement and dopaminergic activity may influence food consumption, but research on whether they interact has not been performed.
Objective: We assessed the effects of food reinforcement and the interaction of food reinforcement with the dopamine transporter (SLC6A3) genotype and the dopamine D(2) receptor (DRD(2)) genotype on energy consumption.
Design: We studied food-consumption and reinforcing-value-of-food tasks in 88 smokers of European ancestry before they enrolled in smoking-cessation treatment.
Health Psychol
September 2003
University of Pennsylvania, Dept of Psychiatry, Abramson Cancer Ctr, Philadelphia, PA 19104, USA.
This study examined the role of dopaminergic genes in prospective smoking cessation and response to bupropion treatment in a placebo-controlled clinical trial. Smokers of European ancestry (N=418) provided blood samples for genetic analysis and received either bupropion or placebo (10 weeks) plus counseling. Assessments included the dopamine D2 receptor (DRD2) genotype, dopamine transporter (SLC6A3) genotype, demographic factors, and nicotine dependence.
View Article and Find Full Text PDFEnter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!